Bridging the Gap: New Study Reveals Unmet Needs in GI Cancer Care
Gastrointestinal (GI) cancers often don't get the same level of attention as other disease states, leaving many patients feeling unheard. In a recent interview, Martha Raymond, Executive Director of the GI Cancers Alliance, discusses a comprehensive year-long study designed to change that by listening directly to the patient community.
Meeting Patients Where They AreThe study aimed to uncover the daily struggles, gaps in services, and supportive needs of patients across the country. Recognizing that every patient is different, the Alliance used a mix of online surveys, focus groups, and personal interviews. This flexible approach allowed them to gather diverse insights from people in everything from major cities like New York to rural communities.
Key Findings: Testing and AccessTwo major themes emerged from the research:
- Inconsistent Biomarker Testing: The study found that biomarker testing is not a standard protocol across all communities. This is a critical gap because without this testing, patients may miss out on precise treatments or endure unnecessary ones. Raymond emphasizes the need to educate patients so they feel empowered to ask for these tests.
- Access Inequities: Heartbreakingly, many diverse patient populations still lack access to life-saving treatments that they know exist.
The Power of CollaborationRaymond concludes that no single organization can solve these systemic issues alone. The path forward lies in collaboration between advocacy groups, pharmaceutical partners, and academic centers. By working together, the GI cancer community can stop "reinventing the wheel" and start closing the gaps in care.
